NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1047 coverThe Communicative Cardiac Cell Volume 1047 published June 2005
Ann. N.Y. Acad. Sci. 1047: 50–65 (2005). doi: 10.1196/annals.1341.005
Copyright © 2005 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by LEV, S.
Articles by GEPSTEIN, L.
Search for Related Content
PubMed
PubMed Citation
Articles by LEV, S.
Articles by GEPSTEIN, L.
Differentiation Pathways in Human Embryonic Stem Cell-Derived Cardiomyocytes

SOPHIE LEV, IZHAK KEHAT AND LIOR GEPSTEIN

The B. Rappaport Institute in the Medical Sciences, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel

Address for correspondence: Lior Gepstein, M.D, Ph.D. The Shonis Family Research Laboratory for the Regeneration of Functional Myocardium. The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, 2 Efron St., POB 9649, Haifa, 31096, Israel. Voice: 972-4-8295303; fax: 972-4-8524758. mdlior{at}tx.technion.ac.il

Human embryonic stem (hES) cells are pluripotent cell lines derived from the inner cell mass of the blastocyst-stage embryo. These unique cell lines can be propagated in the undifferentiated state in culture, while retaining the capacity to differentiate into derivatives of all three germ layers, including cardiomyocytes. The derivation of the hES cell lines presents a powerful tool to explore the early events of cardiac progenitor cell specification and differentiation, and it also provides a novel cell source for the emerging field of cardiovascular regenerative medicine. A spontaneous differentiation system of these stem cells to cardiomyocytes was established and the generated myocytes displayed molecular, structural, and functional properties of early-stage heart cells. In order to follow the in vitro differentiation process, the temporal expression of signaling molecules and transcription factors governing early cardiac differentiation was examined throughout the process. A characteristic pattern was noted recapitulating the normal in vivo cardiac differentiation scheme observed in other model systems. This review discusses the known pathways involved in cardiac specification and the possible factors that may be used to enhance cardiac differentiation of hES cells, as well as the steps required to fully harness the enormous potential of these unique cells.

Key Words: cardiac differentiation • cell therapy • human embryonic stem cells




This article has been cited by other articles:


Home page
CirculationHome page
M. P. Flaherty, A. Abdel-Latif, Q. Li, G. Hunt, S. Ranjan, Q. Ou, X.-L. Tang, R. K. Johnson, R. Bolli, and B. Dawn
Noncanonical Wnt11 Signaling Is Sufficient to Induce Cardiomyogenic Differentiation in Unfractionated Bone Marrow Mononuclear Cells
Circulation, April 29, 2008; 117(17): 2241 - 2252.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Behfar and A. Terzic
Cardioprotective repair through stem cell-based cardiopoiesis
J Appl Physiol, October 1, 2007; 103(4): 1438 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. L.M.A. Beeres, F. M. Bengel, J. Bartunek, D. E. Atsma, J. M. Hill, M. Vanderheyden, M. Penicka, M. J. Schalij, W. Wijns, and J. J. Bax
Role of Imaging in Cardiac Stem Cell Therapy
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1137 - 1148.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Behfar, C. Perez-Terzic, R. S. Faustino, D. K. Arrell, D. M. Hodgson, S. Yamada, M. Puceat, N. Niederlander, A. E Alekseev, L. V. Zingman, et al.
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair
J. Exp. Med., February 19, 2007; 204(2): 405 - 420.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
L. GEPSTEIN
Cardiovascular Therapeutic Aspects of Cell Therapy and Stem Cells
Ann. N.Y. Acad. Sci., October 1, 2006; 1080(1): 415 - 425.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
O. Caspi and L. Gepstein
Stem cells for myocardial repair
Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E43 - E54.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Nemir, A. Croquelois, T. Pedrazzini, and F. Radtke
Induction of Cardiogenesis in Embryonic Stem Cells via Downregulation of Notch1 Signaling
Circ. Res., June 23, 2006; 98(12): 1471 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. E. Murry, H. Reinecke, and L. M. Pabon
Regeneration Gaps: Observations on Stem Cells and Cardiac Repair
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785.
[Abstract] [Full Text] [PDF]



footerLeft footerRight